<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.2: GlycanAge and Proteomic Biomarkers of Longevity</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Advanced Biomarkers */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 40px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.05);
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            padding: 16px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e2e8f0;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        tr:nth-child(even) {
            background: #f8fafc;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #2563eb 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #1e3a8a;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f7ff;
            border-radius: 8px;
            color: #1e3a8a;
            font-size: 15px;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            margin-top: 45px;
            border-radius: 14px;
            border-left: 6px solid #1e3a8a;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 15px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            margin-top: 40px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
            .lesson-container {
                padding: 20px 15px;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Advanced Longevity Diagnostics</p>
            <h1 class="lesson-title">Lesson 12.2: GlycanAge and Proteomic Biomarkers of Longevity</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 2 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The GlycanAge Revolution</a></li>
                <li><a href="#section2"><span class="section-num">2</span>IgG Glycosylation & Inflammaging</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Proteomics: The Functional Snapshot</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Multi-Omic Integration Strategies</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Lifestyle Triggers & Glycan Shifts</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Coaching Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the biological mechanism of IgG glycosylation and its role as a marker for systemic inflammation.</li>
                <li>Differentiate between epigenetic clocks (DNA methylation) and GlycanAge in terms of clinical utility and responsiveness.</li>
                <li>Identify key proteomic biomarkers that predict multi-organ aging and functional decline.</li>
                <li>Analyze the impact of lifestyle variablesâ€”specifically sleep, alcohol, and stressâ€”on glycan patterns.</li>
                <li>Apply multi-omic data to create a targeted intervention plan within the A.G.E.L.E.S.S. Protocolâ„¢.</li>
            </ul>
        </div>

        <h2 id="section1">1. The GlycanAge Revolution: Beyond the Genome</h2>
        <p>While Lesson 12.1 explored the "blueprint" of aging through <span class="highlight">epigenetic clocks</span>, we now shift our focus to the "functional output" of the system. If DNA is the library and epigenetics is the librarian deciding which books to open, <span class="highlight">glycans</span> are the complex sugar molecules that decorate proteins and fundamentally change how those proteins function in real-time.</p>

        <p>Glycans are not directly encoded by DNA. Instead, they are the result of a complex interplay between genetics, environment, and lifestyle. This makes them an exceptionally sensitive <span class="highlight">proxy for biological age</span>. A 2020 study published in <i>GeroScience</i> demonstrated that GlycanAge could predict the onset of age-related diseases up to <span class="stat-highlight">7â€“10 years</span> before clinical symptoms appear.</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Note</p>
            <p>As a Longevity Coach, understanding glycans allows you to show clients a "current state" of their immune system. Unlike epigenetic markers, which can take 6â€“12 months to shift significantly, glycan patterns can reflect lifestyle changes in as little as <span class="stat-highlight">3â€“4 months</span>.</p>
        </div>

        <h2 id="section2">2. IgG Glycosylation: The Molecular Mirror of Inflammaging</h2>
        <p>The most validated longevity application of glycobiology is the analysis of <span class="highlight">Immunoglobulin G (IgG) glycosylation</span>. IgG is the most abundant antibody in human serum. It has a specific site where a complex sugar chain (a glycan) is attached. The composition of this sugar chain determines whether the antibody is <span class="highlight">pro-inflammatory</span> or <span class="highlight">anti-inflammatory</span>.</p>

        <h3>The Glycan Balance: G0 vs. G2</h3>
        <p>The aging process is characterized by a shift in these glycan structures:</p>
        <ul>
            <li><strong>G0 (Aglycosylated):</strong> Lacks terminal galactose. These are highly pro-inflammatory. As we age, G0 levels rise, contributing to the state of <span class="highlight">inflammaging</span>.</li>
            <li><strong>G2 (Diglycosylated):</strong> Contains two terminal galactose molecules. These are anti-inflammatory. High levels of G2 are associated with a "younger" biological age.</li>
        </ul>

        <p>In a massive analysis of <span class="stat-highlight">n=5,117</span> individuals across European populations, researchers found that the ratio of these glycans was more predictive of chronological age and healthspan than traditional markers like CRP or cholesterol (KriÅ¡tiÄ‡ et al., 2014).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Epigenetic Clocks (DNAm)</th>
                        <th>GlycanAge (IgG Glycans)</th>
                        <th>Traditional Bloodwork (CRP/Lipids)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Biological Focus</strong></td>
                        <td>Gene expression potential</td>
                        <td>Immune system & systemic inflammation</td>
                        <td>Metabolic/Organ function</td>
                    </tr>
                    <tr>
                        <td><strong>Response Time</strong></td>
                        <td>Slow (6â€“12 months)</td>
                        <td>Medium (3â€“4 months)</td>
                        <td>Fast (Days to weeks)</td>
                    </tr>
                    <tr>
                        <td><strong>Predictive Power</strong></td>
                        <td>Mortality & specific diseases</td>
                        <td>Inflammaging & biological decline</td>
                        <td>Acute disease risk</td>
                    </tr>
                    <tr>
                        <td><strong>Primary Driver</strong></td>
                        <td>Stem cell aging / Methylation drift</td>
                        <td>Lifestyle, stress, and hormonal balance</td>
                        <td>Diet and immediate physiology</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Proteomics: The Functional Snapshot</h2>
        <p><span class="highlight">Proteomics</span> is the large-scale study of proteins. While the genome is static, the proteome is dynamic, constantly changing in response to internal and external stimuli. In the context of longevity, proteomic profiling allows us to see exactly which "biological machines" are working and which are failing.</p>

        <p>A landmark 2019 study in <i>Nature Medicine</i> identified a "proteomic clock" consisting of <span class="stat-highlight">373 proteins</span> that fluctuate in predictable waves throughout the human lifespan. These waves occur most prominently at ages 34, 60, and 78, suggesting that aging is not a linear process but occurs in distinct physiological shifts.</p>

        <h3>Key Proteomic Markers of Interest</h3>
        <p>When reviewing advanced longevity panels (like those from Olink or SomaLogic), look for these specific clusters:</p>
        <ul>
            <li><strong>GDF15 (Growth Differentiation Factor 15):</strong> Often cited as the single most robust proteomic marker of aging. Elevated levels are associated with mitochondrial dysfunction, cardiovascular risk, and all-cause mortality.</li>
            <li><strong>CCL11 (Eotaxin-1):</strong> A pro-inflammatory cytokine associated with cognitive decline and reduced neurogenesis.</li>
            <li><strong>NPPB (B-type Natriuretic Peptide):</strong> A marker of cardiac stress that often rises decades before a heart failure diagnosis.</li>
        </ul>

        <h2 id="section4">4. Multi-Omic Integration Strategies</h2>
        <p>In the <span class="highlight">A.G.E.L.E.S.S. Longevity Protocolâ„¢</span>, we do not rely on a single marker. The most sophisticated coaches use a <span class="highlight">multi-omic approach</span>. By combining DNA methylation (the blueprint), GlycanAge (the immune state), and Proteomics (the functional execution), we create a high-resolution map of a clientâ€™s longevity.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Fit but Inflamed" Executive</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Integration of GlycanAge and Proteomics</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., Age 52</h4>
                        <p>CEO, Marathon Runner, Low Body Fat (12%)</p>
                    </div>
                </div>
                <p><strong>Presenting Data:</strong> James appeared healthy by traditional standards (Normal BMI, low LDL). However, his <span class="stat-highlight">GlycanAge was 68</span> (16 years older than chronological). His epigenetic clock (DunedinPACE) showed a rate of aging of <span class="stat-highlight">1.15</span> (aging 15% faster than normal).</p>
                <p><strong>Proteomic Findings:</strong> Elevated GDF15 and high levels of pro-inflammatory interleukins (IL-6). James was over-training (15+ hours/week) and sleeping 5.5 hours/night.</p>
                <p><strong>Intervention:</strong> Reduced high-intensity training by 40%, implemented a strict 7.5-hour sleep window, and added 2g of high-quality EPA/DHA daily.</p>
                <p><strong>Outcome:</strong> After 4 months, his GlycanAge dropped to <span class="stat-highlight">54</span>. His GDF15 levels decreased by 22%, indicating reduced mitochondrial stress.</p>
            </div>
        </div>

        <h2 id="section5">5. Lifestyle Triggers & Glycan Shifts</h2>
        <p>Glycans are uniquely sensitive to specific lifestyle "insults." As a coach, you can use GlycanAge as a biofeedback tool to motivate behavior change in areas that are often difficult for clients to prioritize.</p>

        <h3>The "Big Three" Glycan Saboteurs</h3>
        <p><strong>1. Alcohol Consumption:</strong> Alcohol is perhaps the fastest way to age the glycan profile. Studies have shown that even "moderate" drinking (7-10 drinks/week) significantly increases G0 (pro-inflammatory) glycans. In clinical trials, subjects who ceased alcohol for 3 months saw an average GlycanAge reduction of <span class="stat-highlight">4.2 years</span>.</p>

        <p><strong>2. Sleep Deprivation:</strong> Chronic sleep restriction (<5 hours) leads to a rapid "desialylation" of IgG. Sialic acid is a sugar molecule at the end of the glycan chain that is essential for anti-inflammatory signaling. Without it, the immune system remains in a state of high alert.</p>

        <p><strong>3. Perceived Stress & Cortisol:</strong> High cortisol levels inhibit the enzymes (glycosyltransferases) responsible for building "young" glycan structures. This creates a biological link between psychological stress and physical "inflammaging."</p>

        <h2 id="section6">6. Coaching Clinical Application: The A.G.E.L.E.S.S. Framework</h2>
        <p>When integrating these biomarkers into your practice, follow these three steps:</p>
        
        <div class="principle-card">
            <div class="principle-title">Step 1: Establish the Baseline (Assess)</div>
            <p class="principle-text">Order a GlycanAge test alongside a standard longevity panel. Use the GlycanAge as the "hook" to explain that their current lifestyle is manifesting as immune system aging.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 2: Identify the Driver</div>
            <p class="principle-text">Cross-reference high GlycanAge with proteomic markers. If GDF15 is high, focus on mitochondrial health (Exercise/E pillar). If glycans are poor but proteomics are stable, focus on Sleep and Stress (Lifestyle/L pillar).</p>
        </div>

        <div class="principle-card" style="border-left-color: #B8860B;">
            <div class="principle-title">Step 3: The 90-Day Re-Test</div>
            <p class="principle-text">Unlike DNA methylation, which we re-test annually, GlycanAge should be re-tested every 4â€“6 months to validate the intervention's efficacy and maintain client compliance.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why is GlycanAge considered a more "dynamic" marker of biological age than most epigenetic clocks?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">GlycanAge measures the glycosylation of IgG antibodies, which are highly sensitive to current lifestyle factors like sleep, alcohol, and stress. These structures can shift within 3-4 months, whereas epigenetic (DNA methylation) changes typically take much longer to manifest in testing.</p>
            </div>
            <div class="question-item">
                <p class="question-text">Which proteomic marker is currently recognized as the most robust predictor of all-cause mortality and mitochondrial stress?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">GDF15 (Growth Differentiation Factor 15) is the primary proteomic marker associated with mitochondrial dysfunction and is a strong independent predictor of age-related functional decline.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Functional vs. Structural:</strong> GlycanAge and Proteomics provide a "functional" snapshot of health, complementing the "structural" data of epigenetics.</li>
                <li><strong>IgG Glycosylation:</strong> The ratio of G0 (pro-inflammatory) to G2 (anti-inflammatory) glycans is a primary driver of the biological age score.</li>
                <li><strong>Mitochondrial Stress:</strong> Proteomic markers like GDF15 allow coaches to identify mitochondrial dysfunction before it manifests as metabolic disease.</li>
                <li><strong>Intervention Sensitivity:</strong> Glycans are highly responsive to sleep, alcohol cessation, and stress management, making them ideal for short-term behavior tracking.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>KriÅ¡tiÄ‡, J., et al. (2014). "Global and Complement-Specific IgG Glycosylation Are Associated with High-Density Lipoprotein Cholesterol." <i>Nature Communications</i>.</li>
                <li>Lehallier, B., et al. (2019). "Undulating changes in human plasma proteome profiles across the lifespan." <i>Nature Medicine</i>.</li>
                <li>Gudelj, I., Lauc, G., & Pezer, M. (2018). "Immunoglobulin G glycosylation in aging and diseases." <i>Cellular Immunology</i>.</li>
                <li>Valdes, A. M., et al. (2020). "The GlycanAge index as a physiological measure of biological age in healthy adults." <i>GeroScience</i>.</li>
                <li>Wagnon, M. W., et al. (2021). "Proteomic aging clock predicts mortality and age-related phenotypes." <i>Aging Cell</i>.</li>
                <li>Lauc, G., et al. (2016). "Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers." <i>PLOS Genetics</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Anti-Aging & Longevity Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional use only.</p>
        </footer>
    </div>
</body>

</html>